Rafael Justiz, MD
Pain Medicine · Oklahoma City, OKNPI 1043226384
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (30.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medtronic at 36.6% of the total. Reporting peaked in 2020 at $9,436 and has fallen 88.7% since, to $1,065 in 2025.
Across 285 payments — averaging $88.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Aurora Spine, Inc.$7K
- Spinefrontier, Inc.$3K
- Abbott$3K
- Relievant Medsystems, Inc.$1K
- Nevro Corp.$727
- plus $2K from 14 others
Across 11 payments — averaging $2356.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$26K
What the payments were for
- Consulting fees$7,45030%
- Speaking & faculty fees$6,07524%
- Travel & lodging$3,83515%
- Food & beverage$7,66331%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 87 | $9,169 |
| Aurora Spine, Inc. | 4 | $7,450 |
| Spinefrontier, Inc. | 7 | $2,583 |
| Abbott | 127 | $2,521 |
| Relievant Medsystems, Inc. | 8 | $1,040 |
| Nevro Corp. | 17 | $727 |
| Vertos Medical, Inc. | 4 | $404 |
| Boston Scientific | 7 | $335 |
| Globus Medical | 3 | $186 |
| Spinal Simplicity, LLC | 3 | $136 |
| Stryker | 1 | $119 |
| Saluda Medical Americas, Inc. | 1 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $87 |
| Vertiflex, Inc. | 4 | $63 |
| Neuronetics, Inc. | 2 | $62 |
| AbbVie | 1 | $23 |
| GRT US Holding, Inc. | 1 | $20 |
| Valinor Pharma, LLC | 1 | $15 |
| Nalu Medical, Inc. | 1 | $14 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$7,007
- SILO TFX$6,840
- InSpan$2,549
- Sacrix$2,549
- Intracept$1,392
- Proclaim Family of SCS IPGs$577
- mild Device Kit$353
- ZIP$310
- APOLLO ANTERIOR CERVICAL PLATE SYSTEM$300
- INTELLIS ADAPTIVESTIM$296
- Senza$241
- PROCLAIM$177
- Neuromodulation Dspsbls and Accs$146
- INCEPTIV$141
- Vyrsa V1$140
- Senza Spinal Cord Stimulation System$122
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$119
- Evoke$115
- KYPHON EXPRESS II KYPHOPAK TRAY$102
How this compares
$25,082 in reported general payments places this provider in the 85th percentile of 68 pain medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,205 | $33,319 |
| RelistorMethylnaltrexone Bromide | 12 | $32,806 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 471 | $14,575 |
| BelbucaBuprenorphine Hcl | 15 | $11,601 |
| Naloxone Hcl | 181 | $10,493 |
| BelsomraSuvorexant | 14 | $6,097 |
| Pregabalin | 214 | $4,659 |
| Lidocaine | 43 | $3,873 |
| Gabapentin | 234 | $2,333 |
| Oxycodone Hcl | 150 | $2,123 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $2,091 |
| Cyclobenzaprine Hcl | 196 | $1,849 |
| Tizanidine Hcl | 226 | $1,570 |
| Cephalexin | 82 | $1,476 |
| Morphine Sulfate | 41 | $715 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $87 | $32,80612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 68 pain medicine providers in Oklahoma.
Other pain medicine in Oklahoma City
- Sailesh ArulkumarOklahoma City$162K
- Emily PollardOklahoma City$134K
- Tyler PhillipsOklahoma City$36K
- John NelsonOklahoma City$26K
- Atul WaliaOklahoma City$9K
- Ryan VincentOklahoma City$7K
- Liem TrangOklahoma City$6K
- Rico GuerraOklahoma City$3K
- Cooper YatesOklahoma City$2K
- Lawrence AultOklahoma City$617
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.